Nicotine promotes Staphylococcus aureus -induced osteomyelitis by activating the Nrf2/Slc7a11 signaling axis

Xuyou Zhou,Sushuang Ma,Yuan Xu,Chongkai Sun,Juncheng Liao,Mingrui Song,Guanzhi Li,Liu Yuchen,Peng Chen,Yanjun Hu,Yutian Wang,Bin Yu
DOI: https://doi.org/10.1016/j.intimp.2024.112223
IF: 5.714
2024-05-22
International Immunopharmacology
Abstract:Although smoking is a significant risk factor for osteomyelitis, there is limited experimental evidence that nicotine, a key tobacco constituent, is associated with this condition, leaving its mechanistic implications uncharacterized. This study revealed that nicotine promotes Staphylococcus aureus -induced osteomyelitis by increasing Nrf2 and Slc7a11 expression in vivo and in vitro . Inhibition of Slc7a11 using Erastin augmented bacterial phagocytosis/killing capabilities and fortified antimicrobial responses in an osteomyelitis model. Moreover, untargeted metabolomic analysis demonstrated that Erastin mitigated the effects of nicotine on S. aureus -induced osteomyelitis by altering glutamate/glutathione metabolism. These findings suggest that nicotine aggravates S. aureus-induced osteomyelitis by activating the Nrf2/Slc7a11 signaling pathway and that Slc7a11 inhibition can counteract the detrimental health effects of nicotine.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?